Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 11Withdrawn 2Completed 2Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2Advanced Non-squamous Non-small-cell Lung Cancer 2Stomach Neoplasms 1Sarcoma 1Lung Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1

Interventions

Oxaliplatin 20Fluorouracil 20Leucovorin 19Bevacizumab 16Cetuximab 13Irinotecan 12Capecitabine 8regorafenib 5Radiotherapy 5Nivolumab 5Drug Therapy 5aflibercept 4Radiosurgery 4Neoadjuvant Therapy 4Magnetic Resonance Spectroscopy 4Chemotherapy, Adjuvant 4Biopsy 4pembrolizumab 3durvalumab 3atezolizumab 3Specimen Handling 3Folfox protocol 3Cyclophosphamide 3trifluridine tipiracil drug combination 2tremelimumab 2tislelizumab 2poly(I).poly(c12,U) 2futuximab 2fludarabine 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Colorectal Neoplasms × apatinib × Clear all
NCT03228043 2024-11-14

Apatinib for Resectable Colorectal Cancer

Nanchong Central Hospital

Phase NA Withdrawn
Gastrointestinal

Colorectal Neoplasms

NCT03193814 2024-01-03

XHZL

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Withdrawn
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡